Drug intelligence / Profile preview

polyherbal formulation + oseltamivir

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

This is a **combination therapy** of a *polyherbal formulation* (typically derived from Traditional Chinese Medicine formulas such as Yin-Qiao-San and Sang-Ju-Yin, or their components) and **oseltamivir**, an antiviral medication. Oseltamivir is a neuraminidase inhibitor used to treat and prevent influenza A and B by inhibiting the viral neuraminidase, thereby blocking the release of new viral particles. The polyherbal formulation may contain multiple plant-derived components with purported antiviral, immunomodulatory, and anti-inflammatory actions. Studies (such as those examining the combined use of oseltamivir with herbal formulas like CMF1 or with individual herbs like Radix Scutellariae) suggest that polyherbal formulations can alter the pharmacokinetics of oseltamivir, such as increasing the absorbed fraction of oseltamivir and inhibiting its hydrolysis, but do not significantly alter its antiviral activity in vivo[1]. The role of such combinations is primarily being investigated for improved influenza management, especially in traditional medicine contexts.

Other names
oseltamivir and chinese medicinal herbsChinese medicinal herbs + oseltamivir for H1N1 pneumonia
02

Targets

Neuraminidase

Beyond the preview

Go deeper on polyherbal formulation + oseltamivir.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyherbal formulation + oseltamivir.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call